Barbara Messore

Orbassano, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Guidance for Chest-CT in Children and Adults with Cystic Fibrosis: A European Perspective (Part 2: Special Situations/Respiratory Complications).

Guidance for Chest-CT in Children and Adults with Cystic Fibrosis: A European Perspective (Part 2: Special Situations/Respiratory Complications).

Journal: Respiratory medicine

Published: September 29, 2025

COVID-19 in people with Cystic Fibrosis beyond the pre-omicron era: a prospective study with a specific focus on long COVID.

COVID-19 in people with Cystic Fibrosis beyond the pre-omicron era: a prospective study with a specific focus on long COVID.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: January 31, 2025

Guidance for chest-CT in children and adults with cystic fibrosis: A European perspective.

Guidance for chest-CT in children and adults with cystic fibrosis: A European perspective.

Journal: Respiratory medicine

Published: January 06, 2025

Real-world effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis patients with Phe508del -gating and -residual function genotypes.

Real-world effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis patients with Phe508del -gating and -residual function genotypes.

Journal: Respiratory medicine

Published: December 08, 2024

The impact of elexacaftor/tezacaftor/ivacaftor therapy on the pulmonary management of adults with cystic fibrosis: An expert-based Delphi consensus.

The impact of elexacaftor/tezacaftor/ivacaftor therapy on the pulmonary management of adults with cystic fibrosis: An expert-based Delphi consensus.

Journal: Respiratory medicine

Published: May 17, 2023

Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis.

Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: March 20, 2023

Changes in exercise endurance and inspiratory capacity after lumacaftor/ivacaftor therapy in cystic fibrosis.

Changes in exercise endurance and inspiratory capacity after lumacaftor/ivacaftor therapy in cystic fibrosis.

Journal: Pulmonology

Published: July 21, 2022

CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis.

CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis.

Journal: Cells

Published: March 02, 2022

Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society.

Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society.

Journal: Infection

Published: August 09, 2021

Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives.

Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives.

Journal: Antibiotics (Basel, Switzerland)

Published: February 05, 2021

SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020.

SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020.

Journal: PloS one

Published: January 13, 2021

Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function.

Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function.

Journal: Respiratory medicine

Published: April 05, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026